Skip to main content

Archived Comments for: The effect of a controlled manipulation of maternal dietary fat intake on medium and long chain fatty acids in human breast milk in Saskatoon, Canada

Back to article

  1. competing interests

    Valerie McClain, N/A

    22 March 2010

    M. Thomas Clandinin is the President and CEO of BioLipids Inc. in Canada. He is a listed inventor to a US Patent #6998392 called "Formulation to treat or prevent parasitic infection." The formulation is a method of using human milk gangliosides (complex lipids) for placement in infant formula, baby food, etc. MTI Meta Tech Inc. owns the patent and M. Thomas Clandinin is involved with this company, too. I would think that this would be considered a competing interest.

    Competing interests